HDAC9 and endometrial cancer: Li et al. [11] found that a new HDAC inhibitor, FK228, significantly inhibited endometrial cancer cell proliferation and significantly induced apoptosis and cell cycle arrest at the G0/G1 phase in endometrial cancer cells.